Highlights
NASDAQ: ADMS       Adamas Pharma
Last Price Today's Change   Day's Range   Trading Volume
5.29   -0.01 (0.19%)  5.25 - 5.43  141,833

Overview

 
Avg Volume (4 weeks):687,727
4 Weeks Range:3.63 - 6.13
4 Weeks Price Volatility (%):
66.40%
52 Weeks Range:3.35 - 12.57
52 Weeks Price Volatility (%):
21.04%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Adamas Pharmaceuticals Inc was incorporated in the State of Delaware on November 15, 2000. It is a pharmaceutical company focused on the development and commercialization of therapeutics targeting chronic disorders of the central nervous systems. The Company is developing its wholly-owned product candidate, ADS-5102 (amantadine hydrochloride) for a complication associated with the treatment of Parkinson's disease known as levodopa-induced dyskinesia. The Company's portfolio also includes two drugs commercially available in the United States for indications relating to Alzheimer's disease: Namzaric capsules and Namenda XR extended release capsules.

  Be the first to like this.
 


 

2298  3326  415  2925 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GE 12.945+1.215 
 ACHN 6.760.00 
 AMD 46.79-3.74 
 CHK 0.561+0.043 
 AVP 5.60-0.05 
 AABA 19.630.00 
 VIAB 24.22+0.75 
 ECA 3.79-0.25 
 AAPL 326.96+9.27 
Partners & Brokers